Eventum Orthopaedics
Private Company
Total funding raised: $7M
Overview
Eventum Orthopaedics is a private, early-stage med-tech startup from Yorkshire, England, developing data-driven surgical tools for orthopaedics. Its flagship product, Quadsense, is an FDA 510(k)-cleared device that provides real-time intraoperative load data for the kneecap (patellofemoral joint) during knee replacement surgery, addressing a key source of post-operative dissatisfaction. The company is pre-revenue, having secured £1.4 million in funding, and is expanding its platform with a data analytics tool called Datasense. Eventum aims to leverage intraoperative data to improve surgical outcomes and reduce the significant economic burden of revision surgeries and patient dissatisfaction.
Technology Platform
Intraoperative sensing and data analytics platform for real-time measurement of joint biomechanics, starting with patellofemoral load in knee arthroplasty.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Eventum operates in the orthopaedic surgical device market, competing indirectly with major implant manufacturers (e.g., Stryker, Zimmer Biomet, Johnson & Johnson) who offer integrated digital surgery platforms. Its direct competition is limited as Quadsense is first-to-market with real-time patellofemoral load data, but it faces competition from other intraoperative sensing technologies and broader surgical navigation/robotic systems.